EGF816 and Trametinib in Patients With Non-small Cell Lung Cancer and T790M-positive Resistance to EGFR TKI Therapy
about
EGF816 and Trametinib in Patients With Non-small Cell Lung Cancer and T790M-positive Resistance to EGFR TKI Therapy
description
clinical trial
@en
klinisch onderzoek
@nl
name
EGF816 and Trametinib in Patie ...... Resistance to EGFR TKI Therapy
@en
type
label
EGF816 and Trametinib in Patie ...... Resistance to EGFR TKI Therapy
@en
prefLabel
EGF816 and Trametinib in Patie ...... Resistance to EGFR TKI Therapy
@en
P1476
An Open-label, Multicenter, Ph ...... nd Generation EGFR TKI Therapy
@en
P1813
EATON
@en
P3098
NCT03516214
P580
2018-04-25T00:00:00Z
P582
2020-11-25T00:00:00Z